CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects

By Miranda Greenberg -

August 19, 2021

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Biotage.

Formulation Development/Drug Product Manufacturing

Biotage Opens New Facility To Produce Lipids for COVID-19 Vaccines
Biotage, an Uppsala, Sweden-based company that offers products for the purification of large-scale lipids used in mRNA vaccine development and production, has opened a new facility in Cardiff, UK

The company is expanding its production capacity of large-scale flash columns by 300% to assist pharmaceutical companies and contract manufacturers to scale up lipid production for COVID-19 vaccines. The company says that availability of raw materials for mRNA vaccine production has been a bottleneck as the lipids needed for new lipid nanoparticle formulations used in mRNA vaccines were not previously available on the scale needed to produce billions of doses of vaccine globally.

The company says that the newly opened production facility will enable the company to supply this market segment without disruptions in the production of other APIs, fine chemicals, natural products or other products for other markets.

Source: Biotage